NVX-CoV2373 Vaccine Protects Against COVID-19
The adjuvanted recombinant spike protein nanoparticle vaccine, NVX-CoV2373, is effective for the prevention of COVID-19 in adults.
Source: cancertherapyadvisor.com
Stay updated with breaking news from Lisam Dunkle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The adjuvanted recombinant spike protein nanoparticle vaccine, NVX-CoV2373, is effective for the prevention of COVID-19 in adults.